Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LY2189102 in Rheumatoid Arthritis
NCT00380744Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Nov 2005
- Primary completion
- Nov 2007
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 2 trial of ly2189102 in rheumatoid arthritis (RA), sponsored by Eli Lilly and Company. Started Nov 2005; status: completed.
02
Drugs
ly2189102
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00380744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00380744.